Compliance & EnforcementCompliance & Enforcement
ArchiveCompliance & Enforcement
14,104 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Industry-wide Acceptance of Defendant’s Practice Undermines Allegation of Knowing Fraud on FDA; United States Court of Appeals for the Fourth Circuit No. 19-2042, U.S. ex rel. Liubov Skibo and Edward Patt v. Greer Laboratories Inc.
Walmart is No Walgreens: Relator Failed to Show Corporate Policy Influenced Prescription Overfills; United States District Court for the Eastern District of Wisconsin No. 18-CV-840, U.S. ex rel. Jennifer Buth, et al. v. Walmart Inc.
A Rising Tide of Climate-Related Disclosure Requirements?
8(a) Joint Venture Fraud Allegations Lead to False Claims Act Settlement
The Likely Targets of COVID-Related Audits and Investigations
U.K. Treasury Releases Updated Guidance on Sanctions
Russia: Corporate Anti-Corruption Enforcement Trends
Court Certifies Interlocutory Appeal on Whether Misappropriation of Medicaid Funds is Actionable Under the FCA; United States District Court for the Eastern District of New York No. 12-CV-4425 (MKB), U.S. ex rel. Michael Quartararo v. Catholic Health System of Long Island Inc., et al.
Relator Not Entitled to Discovery on Defense Counsels’ Rates; United States District Court for the Northern District of New York No. 1:17-cv-637 (MAD/DJS), U.S. ex rel. Anthonitte Carranza v. Guaranteed Rate Inc. and Victor Ciardelli
Biden Stresses the Importance of Oversight for American Rescue Plan Funds
American Rescue Plan Funds OIG’s Provider Relief Fund Oversight
DOJ Announces $2.2 Billion in 2020 FCA Recoveries and Identifies 2021 Priorities
EU’s New Uniform Whistleblower Laws Might Not Include Rewards
Braskem Discloses New Investigation into Corruption Claims in Mexico
Fourth Circuit Finds Defendants Flagrantly Disregarded Repeated Legal Advice About Illegality of Sales Commissions for Blood Test Services; United States Court of Appeals for the Fourth Circuit No. 18-1811, U.S. ex rel. Scarlett Lutz v. LaTonya Mallory, et al.
Court Mostly Grants Relator’s Motion to Compel Discovery in Pratt & Whitney Fraud Case; U.S. District Court for the District of Connecticut No. 3:16-CV-1730 (AVC), United States ex rel. Peter J. Bonzani Jr. v. United Technologies Corporation, et al.
Managing the Next Big False Claims Act Whistleblower: Your Data
U.S. Supreme Court Declines to Clarify False Claims Act Falsity Standard
Déjà Vu All Over Again: Pandemic Renews Focus on Ongoing False Claims Act Enforcement Priorities
Keep reading
